Combination drug

Results: 675



#Item
611

PDF Document

Add to Reading List

Source URL: www.cdc.gov

Language: English - Date: 2012-03-14 14:32:12
612Fact sheet: Pharmaceutical Company Patient Assistance Programs and Co-Payment Assistance Programs for Pre-exposure Prophylaxis (PrEP) and Post-exposure Prophylaxis (PEP) What is Pre-exposure Prophylaxis (PrEP)? Pre-expos

Fact sheet: Pharmaceutical Company Patient Assistance Programs and Co-Payment Assistance Programs for Pre-exposure Prophylaxis (PrEP) and Post-exposure Prophylaxis (PEP) What is Pre-exposure Prophylaxis (PrEP)? Pre-expos

Add to Reading List

Source URL: www.nastad.org

Language: English - Date: 2013-08-19 13:46:32
613April[removed]Performance Drug List The CVS Caremark Performance Drug List is a guide within select therapeutic categories for clients, plan members and health care providers. Generics should be considered the first line o

April[removed]Performance Drug List The CVS Caremark Performance Drug List is a guide within select therapeutic categories for clients, plan members and health care providers. Generics should be considered the first line o

Add to Reading List

Source URL: www.ct.gov

Language: English - Date: 2014-04-02 08:27:45
614U.S. Food and Drug Administration  Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived

Add to Reading List

Source URL: www.fda.gov

Language: English
615Vaccine Information Statement: DTaP Vaccine - What you need to know

Vaccine Information Statement: DTaP Vaccine - What you need to know

Add to Reading List

Source URL: www.cdc.gov

Language: English - Date: 2013-08-08 16:47:01
616Summary Minutes of the Joint Pulmonary-Allergy Drugs Advisory Committee (PADAC), Drug Safety and Risk Management Advisory Committee (DSaRM), and Pediatric Advisory Committee (PAC) December 10-11, 2008 Location: Hilton Wa

Summary Minutes of the Joint Pulmonary-Allergy Drugs Advisory Committee (PADAC), Drug Safety and Risk Management Advisory Committee (DSaRM), and Pediatric Advisory Committee (PAC) December 10-11, 2008 Location: Hilton Wa

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2009-02-06 14:45:46
617Final Dispute Resolution Guidance Document - Submission and Resolution of Formal Disputes Regarding the Timeliness of Premarket Review of a Combination Product

Final Dispute Resolution Guidance Document - Submission and Resolution of Formal Disputes Regarding the Timeliness of Premarket Review of a Combination Product

Add to Reading List

Source URL: www.fda.gov

Language: English
618Microsoft Word - 9584dft[removed]doc

Microsoft Word - 9584dft[removed]doc

Add to Reading List

Source URL: www.fda.gov

Language: English
619Human Factors Engineering of Combination Products and the FDA Molly Follette Story, PhD FDA /CDRH / ODE Drug Product for Biological Medicines: Novel Delivery Systems, 

Human Factors Engineering of Combination Products and the FDA Molly Follette Story, PhD FDA /CDRH / ODE Drug Product for Biological Medicines: Novel Delivery Systems, 

Add to Reading List

Source URL: www.fda.gov

Language: English
620Actions Taken by FDA Center for Veterinary Medicine  The following corrections or additions to the list were published in the Federal Register in February[removed]Sponsor Change ANADA Number: [removed]

Actions Taken by FDA Center for Veterinary Medicine The following corrections or additions to the list were published in the Federal Register in February[removed]Sponsor Change ANADA Number: [removed]

Add to Reading List

Source URL: www.fda.gov

Language: English